health canada semaglutide approves first generic version of Ozempic amid rising GLP-1 competition A more affordable alternative to

For readers thinking about which Act-2 molecule to follow over the next several years, biased-signaling design is a clue about the philosophy of the next decade, and a reason to be skeptical of any framing that treats efficacy as the only axis

For example, some gut microbes produce short-chain fatty acids that have been shown to stimulate GLP-1 secretion in the gut

With Doctronic, you can get immediate, AI-powered medical advice that's fast, smart, and personal

Mitochondrial dysfunction is recognized as one of the primary hallmarks of biological aging, and MOTS-c directly addresses this mechanism

Leduc, D., Gallaud, J., Stingl, K